检索结果 - Kevin W. Bailey
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment 由 Dionna Scharton, Kevin W. Bailey, Zachary Vest, Jonna B. Westover, Yohichi Kumaki, Arnaud J. Van Wettere, Yousuke Furuta, Brian B. Gowen
出版 2014Artigo -
5
-
6
Evaluation of Immunomodulators, Interferons and Known <i>in Vitro</i> SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice 由 Dale L. Barnard, Craig W. Day, Kevin W. Bailey, Matthew Heiner, Robert A. Montgomery, Larry Lauridsen, Paul K.S. Chan, Robert W. Sidwell
出版 2006Artigo -
7
-
8
-
9
Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin 由 Brian B. Gowen, Donald F. Smee, Min‐Hui Wong, Jeffery O. Hall, Kie‐Hoon Jung, Kevin W. Bailey, John R. Stevens, Yousuke Furuta, John D. Morrey
出版 2008Artigo -
10
Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin 由 Yohichi Kumaki, Miles K. Wandersee, Aaron Smith, Yanchen Zhou, Graham Simmons, Nathan M. Nelson, Kevin W. Bailey, Zachary Vest, Joseph K.-K. Li, Paul K.S. Chan, Donald F. Smee, Dale L. Barnard
出版 2011Artigo -
11
Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses 由 Jonna B. Westover, Eric J. Sefing, Kevin W. Bailey, Arnaud J. Van Wettere, Kie‐Hoon Jung, Ashley Dagley, Luci Wandersee, Brittney Downs, Donald F. Smee, Yousuke Furuta, Mike Bray, Brian B. Gowen
出版 2015Artigo -
12
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin 由 Dale L. Barnard, Craig W. Day, Kevin W. Bailey, Matthew Heiner, Robert A. Montgomery, Larry Lauridsen, Scott Winslow, Justin D. Hoopes, Joseph K.-K. Li, Jong‐Dae Lee, Dennis A. Carson, Howard B. Cottam, Robert W. Sidwell
出版 2006Artigo -
13
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress 由 Lauren E. Williamson, Kristen M. Reeder, Kevin W. Bailey, Minh H. Tran, Vicky Roy, Mallorie E. Fouch, Nurgun Kose, Andrew Trivette, Rachel S. Nargi, Emma S. Winkler, Arthur S. Kim, Christopher Gainza, Jessica Rodríguez, Erica Armstrong, Rachel E. Sutton, Joseph X. Reidy, Robert H. Carnahan, W. Hayes McDonald, Clara T. Schoeder, William B. Klimstra, Edgar Davidson, Benjamin J. Doranz, Galit Alter, Jens Meiler, Kevin L. Schey, Justin G. Julander, Michael Diamond, James E. Crowe
出版 2021Artigo
相关主题
Virology
Virus
Biology
Internal medicine
Medicine
Immunology
Disease
Infectious disease (medical specialty)
Coronavirus disease 2019 (COVID-19)
Hepatitis C virus
Ribavirin
Pharmacology
Antiviral drug
Favipiravir
Immune system
Influenza A virus
Oseltamivir
Arenavirus
Bunyaviridae
CD8
Lymphocytic choriomeningitis
Microbiology
Neuraminidase inhibitor
Phlebovirus
Titer
Viral replication
Hamster
Junin virus
Lethal dose
Neuraminidase